Trends in Prostate Cancer Incidence and Mortality in New Mexico are Consistent With an Increase in Effective Screening

Cancer Epidemiology Biomarkers and Prevention

Volumn 3, Issue 2, 1994, Pages 105-111

  Gilliland, Frank ^a   Becker, Thomas M ^a   Smith, Anthony ^a   Key, Charles R ^a   Samet, Jonathan M ^a  

^a UNIVERSITY OF NEW MEXICO SCHOOL OF MEDICINE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

TUMOR ANTIGEN;

ADULT; AGED; ANTIGEN DETECTION; ARTICLE; CANCER INCIDENCE; CANCER MORTALITY; CANCER SCREENING; CANCER STAGING; CANCER SURVIVAL; EARLY DIAGNOSIS; HUMAN; HUMAN CELL; HUMAN TISSUE; MAJOR CLINICAL STUDY; MALE; PRIORITY JOURNAL; PROSTATE CANCER; UNITED STATES; UROGENITAL SYSTEM EXAMINATION;

AGED; COHORT STUDIES; CROSS-SECTIONAL STUDIES; HUMAN; INCIDENCE; MALE; MASS SCREENING; MIDDLE AGE; NEOPLASM STAGING; NEW MEXICO; PROSTATE; PROSTATECTOMY; PROSTATIC NEOPLASMS; SUPPORT, U.S. GOV'T, P.H.S.; SURVIVAL ANALYSIS; SURVIVAL RATE;

EID: 0028339414     PISSN: 10559965     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (52)

1. Miller, A. Screening for cancer of the cervix. In: A. Miller (ed.), Screening for Cancer, pp. 295–320. Orlando: Academic Press, 1985.
2. Mandel, J. S., and Schuman, L. M. Epidemiology of prostate cancer. In: A. M. Lilienfeld (ed.), Reviews in Cancer Epidemiology, Vol 1. pp. 1–83. New York: Elsevier, 1980.
3. Mettlin, C., Jones, G. W., and Murphy, G. P. Trends in prostate cancer care in the United States, 1974-1990: observations from the patient care evaluation studies of the American College of Surgeons Commission on Cancer. CA Cancer J. Clin., 43: 83–91, 1993.
4. Walsh, P. C. Why make an early diagnosis of prostate cancer? J. Urol., 147: 853–854, 1992.
5. Chodak, G. Prostate cancer: to screen or not to screen. Acta Oncol., 30: 285–287, 1991.
6. Mettlin, C., Jones, G., Averette, H., Gusberg, S. B., and Murphy, G. P. Defining and updating the American Cancer Society Guidelines for the cancer-related checkup: Prostate and endometrial cancers. CA Cancer J. Clin., 43: 42–46, 1993.
7. Thompson, S., and Resnick, M. Screening for prostate cancer. In: H. Lepor and R. Lawson (eds.), Prostate Diseases, pp. 293–304. Philadelphia: W. B. Saunders, 1993.
8. Chamberlain, J. Planning of screening programmes for evaluation and nonrandomized approaches to evaluation. In: P. C. Prorok and A. B. Miller (eds.), Screening for Cancer: I. General Principles on Evaluation of Screening for Cancer and Screening for Lung, Bladder and Oral Cancer, Vol. 78. Geneva: UICC, 1984.
9. Miller, A. Fundamentals of Screening. In: A. Miller (ed.), Screening for Cancer, pp. 3–24. Orlando: Academic Press, 1985.
10. Key, C. R. Cancer incidence and mortality in New Mexico, 1973-77. In: J. L. Young, C. L. Percy, and A. J. Asire (eds.), Surveillance, Epidemiology and End Results (SEER): Incidence and Mortality Data, 1973-1977. pp. 489–595. Washington, DC: United States Printing Office, 1981.
11. Percy, C., Van Holten, V., and Muir, C. International Classification of Diseases for Oncology, Ed. 2. Geneva: World Health Organization, 1990.
12. Shambaugh, E. M., Gloeckler Ries, L., Young, J. L., and Kruse, M. A. SEER extent of disease 1988 codesand coding instructions. Bethesda, MD: National Cancer Institute, 1992.
13. Cunningham, J., Hankey, B., Lyles, B., Percy, C., Ries, L., Seiffert, J., Shambaugh, E., and Van Holten, V., Eds. The SEER Program Code Manual. Revised edition. Bethesda, MD: National Cancer Institute, 1992.
14. Shambaugh, E. M., Weiss, M. A., Ries, L. A. G., Van Holten, V., Kruse, M. A., Cunningham, J. B., Lyles, B. A., and Ryan, R. F. Comparative staging guide for cancer. Bethesda, MD: United States Department of Health and Human Services, 1993.
15. United States Department of Health and Human Services. Summary Staging Guide for the Cancer Surveillance, Epidemiology and End Results Reporting (SEER) Program. Bethesda, MD: Public Health Service, NIH, 1986.
16. United States Bureau of the Census. Census of the Population, 1960: General Population Characteristics. Final Report. New Mexico. Washington, DC: United States Government Printing Office, 1961.
17. United States Bureau of the Census. Census of the Population, 1960: Subject Reports: Persons of Spanish Surnames. Final Report. New Mexico. Washington, DC: United States Government Printing Office, 1963.
18. United States Bureau of the Census. Census of the Population, 1960: Subject Reports: Non-White Persons by Race. Final Report. New Mexico. Washington, DC: United States Government Printing Office, 1963.
19. United States Bureau of the Census. Census of the Population, 1970: General Population Characteristics. Final Report. New Mexico. Washington, DC: United States Government Printing Office, 1971.
20. United States Bureau of the Census. Census of the Population, 1970: General Social and Economic Characteristics. Washington, DC: United States Government Printing Office, 1971.
21. United States Bureau of the Census. Census of the Population, 1970: Subject Reports. Final Report. New Mexico. Washington, DC: United States Government Printing Office, 1973.
22. United States Bureau of the Census. Census of the Population, 1980: General Population Characteristics. Final Report. New Mexico. Washington, DC: United States Government Printing Office, 1981.
23. United States Bureau of the Census. Census of the Population, 1990: General Population Characteristics. Final Report. New Mexico. Washington, DC: United States Government Printing Office, 1990.
24. Miller, B. A., Ries, L. A. G., Hankey, B. F., Kosary, C. L., and Edwards, B. K. Cancer Statistics Review: 1973-1989, National Cancer Institute, 1992.
25. Ederer, F., Axtell, L. M., and Cutler, S. J. The relative survival rate: a statistical methodology. Nat. Cancer Inst. Monogr., 6: 101–121, 1961.
26. SAS Institute Inc. SAS User's Guide: Statistics, Ver. 6. Cary, NC: SAS Institute, 1990.
27. Joos, R. E. Hospital PC System User's Manual. Salt Lake City: Utah Cancer Registry, 1986.
28. Crawford, E., DeAntoni, E., Stone, N., and Blum, D. Prostate cancer awareness week: benefits and shortcomings of community-based screening for prostate cancer. Urology, 149: 214a, 1993.
29. Thompson, I. M., Rounder, J. B., Teague, J. L., Peek, M., and Spence, C. Impact of routine screening for adenocarcinoma of the prostate on stage distribution. Urology, 137: 424–426, 1987.
30. Chodak, G. W., Keller, P., and Schoenberg, H. W. Assessment of screening for prostate cancer using the digital rectal examination. Urology, 141: 1136–1138, 1989.
31. Littrup, P. J., Lee, F., and Mettlin, C. Prostate cancer screening: current trends and future implications. CA Cancer J. Clin., 42: 198–211, 1992.
32. Catalona, W. J., Smith, D. S., Ratliff, T. L., and Basler, J. W. Detection of organ-confined prostate cancer is increased through prostate-specific antigen-based screening. JAMA, 270: 948–954, 1993.
33. Thompson, I. M., and Fair, W. R. Screening for carcinoma of the prostate: Efficacy of available screening tests. World J. Surg., 13: 65–70, 1989.
34. Thompson, I. M., Ernst, J. J., Gangai, M. P., and Spence, C. R. Adenocarcinoma of the Prostate: Results of routine urological screening. Urology, 732: 690–692, 1984.
35. Mueller, E. J., Crain, T. W., Thompson, I. M., and Rodriguez, F. R. An evaluation of serial digital rectal examinations in screening for prostate cancer. Urology, 140: 1445–1447, 1988.
36. Gerber, G. S., Thompson, I. M., Thisted, R., and Chodak, G. W. Disease-specific survival following routine prostate cancer screening by digital rectal examination. JAMA, 269: 61–64, 1993.
37. Lange, P. H. The next era for prostate cancer. JAMA, 269: 95–96, 1993.
38. Johansson, J. E., Andersson, S. O., Krusemo, U. B., Adam, H. O., Bergstrom, R., and Kraaz, W. Natural history of localised prostatic cancer. Lancet, 7: 799–803, 1989.
39. Whitmore, W., Warner, J., and Thompson, I. Expectant Management of Localized Prostatic Cancer. Cancer (Phila.), 67: 1091–1096, 1991.
40. New Mexico Department of Health. 1991 New Mexico Selected Health Statistics. Santa Fe: New Mexico Department of Health, 1993.
41. Lu-Yao, G. L., McLerran, D., Wasson, J., and Wennberg, J. E. An Assessment of Radical Prostatectomy: Time trends, geographic variation, and outcomes. JAMA, 269: 2633–2636, 1993.
42. Potosky, A. L., Kessler, L., Gridley, G., Brown, C. C., and Horm, J. W. Rise in prostatic cancer incidence associated with increased use of transurethral resection. J. Natl. Cancer Inst., 82: 1624–1628, 1990.
43. New Mexico Tumor Registry. State of New Mexico: Malignancies Diagnosed, 1990. Albuquerque: University of New Mexico Medical Center, 1990.
44. Mandel, J. S., and Schuman, L. M. Sexual factors and prostatic cancer: results from a case-control study. J. Gerontol., 42: 259, 1987.
45. Nomura, A., and Kolonel, L. Prostate cancer: A current perspective. Am. J. Epidemiol., 73: 200–227, 1991.
46. Wiggins, C. L., and Samet, J. M. Methods. In: T. M. Becker, C. L. Wiggins, R. S. Elliott, C. R. Key, and J. M. Samet (eds.), Racial and Ethnic Patterns of Mortality in New Mexico. Albuquerque: University of New Mexico Press, 1993.
47. Wiggins, C. L., Becker, T. M., Key, C. R., and Samet, J. M. Stomach cancer among New Mexico's American Indians, Hispanic whites, and non-Hispanic whites. Cancer Res., 49: 1595–1599, 1989.
48. Percy, C., Stanek, E., and Gloeckler, L. Accuracy of cancer death certificates and its effect on cancer mortality statistics. Am. J. Public Health, 77: 242–250, 1981.
49. Rosenberg, H. Improving the quality of death certificates. Am. J. Public Health, 79: 563–564, 1989.
50. Kircher, T., Nelson, J., and Burdo, H. The autopsy as a measure of accuracy of the death certificate. N. Eng. J. Med., 373: 1267–1273, 1985.
51. Chodak, G. W., and Schoenberg, H. W. Progress and problems in screening for carcinoma of the prostate. World J. Surg., 73: 60–64, 1989.
52. Catalona, W. Urology. JAMA, 260: 265–266, 1993.